BrightSpring Health Services, Inc. Common Stock (BTSG) Earnings Analysis

BrightSpring Health Services, Inc. Common Stock (BTSG) next reports earnings on 2026-07-31, consensus EPS 0.3963 USD. Last quarter (2026-05-01) it beat with EPS 0.39 USD vs 0.29 USD est (+34.5%). It has beaten estimates in 5/8 recent quarters (63%). Trailing P/E 45.88.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does BTSG next report earnings?

Next earnings date2026-07-31
Consensus EPS estimate0.3963 USD
Revenue estimate3.66B

BTSG earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-010.39 USD0.29 USD+34.5%Beat
2026-02-270.33 USD0.34 USD-2.9%Miss
2025-10-310.3 USD0.2635 USD+13.9%Beat
2025-08-010.22 USD0.19 USD+15.8%Beat
2025-05-020.19 USD0.08 USD+137.5%Beat
2025-03-060.22 USD0.19 USD+15.8%Beat
2024-11-010.11 USD0.18 USD-38.9%Miss
2024-08-020.1 USD0.17 USD-41.2%Miss

Beat rate: 5/8 (63%) over reported quarters with consensus data.

BTSG valuation and analyst view

Trailing P/E45.88
Trailing EPS1.514 USD
Price / book7.21
Dividend yield0.00%
Market cap14.05B
Analyst consensusBuy (12 buy / 0 hold / 0 sell)
Avg price target72.17 USD

Related research pages

Frequently asked questions

When is BrightSpring Health Services, Inc. Common Stock (BTSG)'s next earnings date?

BrightSpring Health Services, Inc. Common Stock is next scheduled to report on 2026-07-31, with a consensus EPS estimate of 0.3963 USD and revenue estimate of 3.66B.

Did BTSG beat earnings last quarter?

In its 2026-05-01 report, BTSG posted EPS of 0.39 USD versus a 0.29 USD estimate — a beat of 34.5%.

What is BTSG's earnings track record?

Over the last 8 reported quarters with consensus data, BTSG beat estimates 5 times (63%).

What is BTSG's current P/E ratio and EPS?

BTSG trades at a trailing P/E of 45.88 on trailing EPS of 1.5137901051232951 USD.

What do analysts rate BTSG?

Analyst consensus is "Buy" across 12 ratings (0 strong buy, 12 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 72.17 USD.